Literature DB >> 33725201

Profiles of current COVID-19 vaccines.

Franz X Heinz1, Karin Stiasny2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33725201      PMCID： PMC7962631          DOI： 10.1007/s00508-021-01835-w

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  76 in total

1.  Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.

Authors:  Katalin Karikó; Michael Buckstein; Houping Ni; Drew Weissman
Journal:  Immunity       Date:  2005-08       Impact factor: 31.745

Review 2.  New insights on adenovirus as vaccine vectors.

Authors:  Marcio O Lasaro; Hildegund C J Ertl
Journal:  Mol Ther       Date:  2009-06-09       Impact factor: 11.454

3.  Structures and distributions of SARS-CoV-2 spike proteins on intact virions.

Authors:  Zunlong Ke; Joaquin Oton; Kun Qu; Mirko Cortese; Vojtech Zila; Lesley McKeane; Takanori Nakane; Jasenko Zivanov; Christopher J Neufeldt; Berati Cerikan; John M Lu; Julia Peukes; Xiaoli Xiong; Hans-Georg Kräusslich; Sjors H W Scheres; Ralf Bartenschlager; John A G Briggs
Journal:  Nature       Date:  2020-08-17       Impact factor: 49.962

Review 4.  Understudied Factors Influencing Fc-Mediated Immune Responses against Viral Infections.

Authors:  Sai Priya Anand; Andrés Finzi
Journal:  Vaccines (Basel)       Date:  2019-08-30

Review 5.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development.

Authors:  Tiffany Tang; Miya Bidon; Javier A Jaimes; Gary R Whittaker; Susan Daniel
Journal:  Antiviral Res       Date:  2020-04-06       Impact factor: 5.970

6.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

Authors:  Daniel Wrapp; Nianshuang Wang; Kizzmekia S Corbett; Jory A Goldsmith; Ching-Lin Hsieh; Olubukola Abiona; Barney S Graham; Jason S McLellan
Journal:  Science       Date:  2020-02-19       Impact factor: 47.728

7.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Authors:  Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Andrea M Collins; Rachel Colin-Jones; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Anna L Goodman; Catherine M Green; Christopher A Green; Paul T Heath; Catherine Hill; Helen Hill; Ian Hirsch; Susanne H C Hodgson; Alane Izu; Susan Jackson; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Alison M Lawrie; Alice Lelliott; Vincenzo Libri; Patrick J Lillie; Raburn Mallory; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Hazel Morrison; Yama F Mujadidi; Anusha Nana; Peter J O'Reilly; Sherman D Padayachee; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Alexandre V Schwarzbold; Nisha Singh; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Richard Tarrant; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Marion E E Watson; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-12-08       Impact factor: 79.321

8.  Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.

Authors:  Alexander Muik; Ann-Kathrin Wallisch; Bianca Sänger; Kena A Swanson; Julia Mühl; Wei Chen; Hui Cai; Daniel Maurus; Ritu Sarkar; Özlem Türeci; Philip R Dormitzer; Uğur Şahin
Journal:  Science       Date:  2021-01-29       Impact factor: 47.728

9.  In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges.

Authors:  Beata Turoňová; Mateusz Sikora; Christoph Schürmann; Wim J H Hagen; Sonja Welsch; Florian E C Blanc; Sören von Bülow; Michael Gecht; Katrin Bagola; Cindy Hörner; Ger van Zandbergen; Jonathan Landry; Nayara Trevisan Doimo de Azevedo; Shyamal Mosalaganti; Andre Schwarz; Roberto Covino; Michael D Mühlebach; Gerhard Hummer; Jacomine Krijnse Locker; Martin Beck
Journal:  Science       Date:  2020-08-18       Impact factor: 47.728

10.  The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET.

Authors:  Chuang Liu; Luiza Mendonça; Yang Yang; Yuanzhu Gao; Chenguang Shen; Jiwei Liu; Tao Ni; Bin Ju; Congcong Liu; Xian Tang; Jinli Wei; Xiaomin Ma; Yanan Zhu; Weilong Liu; Shuman Xu; Yingxia Liu; Jing Yuan; Jing Wu; Zheng Liu; Zheng Zhang; Lei Liu; Peiyi Wang; Peijun Zhang
Journal:  Structure       Date:  2020-10-15       Impact factor: 5.006
View more
  14 in total

1.  COVID-19 mRNA vaccination leading to CNS inflammation: a case series.

Authors:  Mahsa Khayat-Khoei; Shamik Bhattacharyya; Joshua Katz; Daniel Harrison; Shahamat Tauhid; Penny Bruso; Maria K Houtchens; Keith R Edwards; Rohit Bakshi
Journal:  J Neurol       Date:  2021-09-04       Impact factor: 6.682

Review 2.  The impact of spike mutated variants of SARS-CoV2 [Alpha, Beta, Gamma, Delta, and Lambda] on the efficacy of subunit recombinant vaccines.

Authors:  Mehrdad Mohammadi; Mohammad Shayestehpour; Hamed Mirzaei
Journal:  Braz J Infect Dis       Date:  2021-08-17       Impact factor: 3.257

3.  Vaccine-associated complications: a comparative multicenter evaluation among dental practitioners and dental students-which candidate vaccine is more safe in SARS COV II, Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBP-CorV(Sinopharm)?

Authors:  Behzad Houshmand; Seied Omid Keyhan; Hamid Reza Fallahi; Shaqayeq Ramezanzade; Erfan Sadeghi; Parisa Yousefi
Journal:  Maxillofac Plast Reconstr Surg       Date:  2022-01-13

Review 4.  Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines.

Authors:  Heedo Park; Mee Sook Park; Jong Hyeon Seok; Jaehwan You; Jineui Kim; Jeonghun Kim; Man-Seong Park
Journal:  J Microbiol       Date:  2022-03-02       Impact factor: 2.902

Review 5.  COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants.

Authors:  Rashed Noor; Saadia Shareen; Muntasir Billah
Journal:  Bull Natl Res Cent       Date:  2022-04-08

Review 6.  mRNA Vaccines as an Efficient Approach for the Rapid and Robust Induction of Host Immunity Against SARS-CoV-2.

Authors:  Rashed Noor
Journal:  SN Compr Clin Med       Date:  2022-04-01

Review 7.  A review on the induction of host immunity by the current COVID-19 vaccines and a brief non-pharmaceutical intervention to mitigate the pandemic.

Authors:  Rashed Noor
Journal:  Bull Natl Res Cent       Date:  2022-02-16

Review 8.  A Review on the Effectivity of the Current COVID-19 Drugs and Vaccines: Are They Really Working Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants?

Authors:  Rashed Noor
Journal:  Curr Clin Microbiol Rep       Date:  2021-07-03

Review 9.  Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2.

Authors:  Javier T Granados-Riveron; Guillermo Aquino-Jarquin
Journal:  Biomed Pharmacother       Date:  2021-07-23       Impact factor: 6.529

10.  The psychological resilience and perceived stress of the frontline heroes in the pandemic in Turkey: A descriptive study of the COVID-19 outbreak-mutations-normalization triad.

Authors:  Maruf Boran; Omer Faruk Boran; Oznur Korukcu; Meltem Özkaya
Journal:  Jpn J Nurs Sci       Date:  2021-07-20       Impact factor: 1.691
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.